Guide
Peptide therapy safety and side effects
An honest accounting of the risks — including the supply-chain risks that come from compounded medication rather than the molecule itself.
Peptide therapy is not risk-free, and the risks differ enormously by compound. Here's an honest
accounting — including the risks that come from the supply chain rather than the molecule.
GLP-1 side effects: what's common, what's serious
| Frequency | Effects |
|---|
| Common (usually fade) | Nausea, reduced appetite, constipation, diarrhea, fatigue, injection-site reactions |
| Less common | Gallbladder issues, hair thinning, significant muscle loss if protein/resistance training are neglected |
| Serious — seek care | Pancreatitis (severe persistent abdominal pain), severe allergic reaction, vision changes |
Boxed warning
Semaglutide, tirzepatide, and liraglutide carry an FDA boxed warning for thyroid C-cell tumors. They are
contraindicated if you have a personal or family history of medullary thyroid carcinoma (MTC) or multiple
endocrine neoplasia syndrome type 2 (MEN2). Disclose this at intake — it is not a formality.
The risk most reviews skip: the supply chain
With compounded medication, a real fraction of the risk isn't the molecule — it's whether the vial
contains what the label says, at the stated concentration, without contamination. Dosing errors from
multi-dose vials and inconsistent compounding are a documented driver of adverse events in this category.
This is precisely why pharmacy sourcing carries 25% of our
score, and why providers that publish per-batch testing rate higher.
Recovery and longevity peptides: a different problem
BPC-157, TB-500, epitalon and similar compounds have a
thin human safety record — not
because they've been shown to be dangerous, but because they've barely been studied in humans. "No known
serious side effects" and "well-studied and safe" are very different statements. Read the evidence at
PeptideOnline.
How to reduce your risk, concretely
- Get baseline bloodwork even if your provider doesn't require it.
- Disclose your full history at intake — especially thyroid, pancreas, and gallbladder.
- Choose a provider that names its pharmacy and publishes batch testing.
- Titrate slowly. Most GI side effects come from escalating too fast.
- Prioritize protein intake and resistance training on a GLP-1 to protect lean mass.
- Never improvise reconstitution math. Confirm units-per-dose in writing.
FAQ
Are peptides safe?
It depends on the peptide. GLP-1s have a large human safety database and a known side-effect profile plus a boxed warning for thyroid C-cell tumors. BPC-157 and many longevity peptides have a thin human safety record — not proven dangerous, just barely studied. Those are different situations and shouldn't be described with the same word.
What are the most common GLP-1 side effects?
Nausea, reduced appetite, constipation, diarrhea, and fatigue — usually worst during dose escalation and fading as you adjust. Severe persistent abdominal pain can indicate pancreatitis and warrants immediate medical attention.
Who should not take GLP-1 medications?
Anyone with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome (boxed warning), and anyone with a history of pancreatitis should proceed only with careful clinical supervision. Disclose fully at intake.
Medical disclaimer: Veritide is an independent consumer-research publication, not a healthcare provider or pharmacy. This page is informational and is not medical advice. Compounded medications are not FDA-approved as finished products. Always consult a licensed clinician before starting any peptide or GLP-1 therapy.